About Currax
Currax is a Healthcare company based in Brentwood (United States). Currax Pharmaceuticals is engaged in distributing life-changing medications worldwide. It operates on a Direct-to-Consumer (D2C) model. Currax has completed 2 acquisitions, including Nalpropion Pharmaceuticals and Pernix. Currax offers products and services including Contrave®, Onzetra® Xsail®, Silenor®, and Treximet®. Its focus areas include Pharmaceuticals and Prescription Drugs.
Company details
Currax Pharmaceuticals LLC is involved in the distribution of innovative, life-changing medicines to patients with chronic and progressive diseases globally. A range of branded and generic pharmaceutical products, including Contrave, Onzetra Xsail, Silenor, and Treximet, are provided by the company. The focus is placed on enhancing patient lives through access to critical treatments in the healthcare sector.
- Headquarters Brentwood, United States
- SectorsHealthcare
- Phone•••• ••••
- Website curraxpharma.com
- Investments & AcquisitionsNalpropion Pharmaceuticals
& 1 more
Products & Services of Currax
Currax offers a comprehensive portfolio of products and services, including Contrave®, Onzetra® Xsail®, Silenor®, and Treximet®.
Medication for obesity treatment is distributed by Currax.
Migraine treatment medication is provided by Currax Pharmaceuticals.
Insomnia treatment drug is offered by Currax Pharmaceuticals.
Migraine relief medication is distributed by Currax Pharmaceuticals.
People of Currax
84 people are tracked at Currax (24 in leadership, 60 in team).
| Name | Role | Group |
|---|---|---|
Jason Richardson | Director Of IT | Leadership |
Aaron Baratta | VP, Sales | Leadership |
Terry Evans | COO | Leadership |
Michael Kyle | Chief Medical Officer | Leadership |
Laura Lustig | VP, Human Resources | Leadership |
George Hampton | CEO | Leadership |
Bill Kirkland | Supply Chain Director | Leadership |
Dayna Bauman | Senior Director, Trade And Distribution | Leadership |
Om Sharma | Sr. Director, Clinical Lead | Leadership |
Scott Steres | Area Sales Director | Leadership |
Lisa Dreher | Director, National Sales Training | Leadership |
Brian Rigney | Area Sales Director West | Leadership |
Colton Cline | Vice President, Associate General Counsel | Leadership |
Pamela Appel | Sr Director, Medical Affairs Strategy And Engagement | Leadership |
Kajal Shinde | Associate Director (drug Safety And Pharmacovigilance) | Leadership |
Lawrence K. Anochie | Director Of Drug Safety & Pharmacovigilance | Leadership |
Diane Stevens | Human Resources Director | Leadership |
Anthony Orrico | Vice President Technical And Supply Operations | Leadership |
Sharmili Datta | Director Tech Ops | Leadership |
Aaron Chesnut | VP, Technical Operations | Leadership |
64 more people are available in the full profile.
Complete people profiles for Currax
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Currax
Currax has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Nalpropion Pharmaceuticals and Pernix.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Branded and generic pharmaceutical products are distributed across therapeutic areas. | nalpropion.com | San Diego, United States | 2018 | Sep 2019 | •••• | |
Pharmaceutical company manufacturing and marketing drugs for pediatric market | pernixtx.com | The Woodlands, United States | 1997 | May 2019 | $75.6M |
Complete acquisition details for Currax
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Currax
2 dated milestones of Currax, from founding to its latest funding, stage changes and deals.
- Acquisition Acquires Pernix.
- Acquisition Acquires Nalpropion Pharmaceuticals.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Currax (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Currax
Currax is headquartered in Brentwood, United States.
Currax Pharmaceuticals LLC is involved in the distribution of innovative, life-changing medicines to patients with chronic and progressive diseases globally. A range of branded and generic pharmaceutical products, including Contrave, Onzetra Xsail, Silenor, and Treximet, are provided by the company. The focus is placed on enhancing patient lives through access to critical treatments in the healthcare sector.
Currax offers Contrave®, Onzetra® Xsail®, Silenor®, and Treximet®.
Currax has made 2 acquisitions, including Nalpropion Pharmaceuticals, and Pernix.